Valence Life Sciences
Overview
Valence Life Sciences is a New York-based firm focused on late-stage investments in companies across the United States . It is the only life sciences venture firm with a proven record of success in late-stage investing . Their team has insight on what drives success from assessing management and clinical development plans for over 25 years .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mevion Medical Systems | Jan 2012 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Valence Life Sciences based?
Valence Life Sciences is headquartered in New York City, New York, United States.
When was Valence Life Sciences founded?
Valence Life Sciences was founded in 2012.
How many portfolio companies does Valence Life Sciences have?
Valence Life Sciences has 1 portfolio company in Caplight's dataset.
What are some companies in Valence Life Sciences's portfolio?
Portfolio companies visible on Caplight include Mevion Medical Systems.
What was Valence Life Sciences's most recent investment shown here?
Valence Life Sciences's most recent investment in this portfolio sample was in Mevion Medical Systems in 2012.
What sectors does Valence Life Sciences focus on?
Valence Life Sciences focuses on Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Valence Life Sciences focus on?
Valence Life Sciences typically invests at the Early stage.
What is Valence Life Sciences's AUM?
Valence Life Sciences's assets under management are estimated between $100.0M and $250.0M.